Cart
sales@molnova.com
Salcaprozate sodium
CAS No. 203787-91-1
Salcaprozate sodium( SNAC )
Catalog No. M23911 CAS No. 203787-91-1
Salcaprozate sodium is an oral absorption promoter, and has the potential as a delivery agent for oral forms of heparin and insulin.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 53 | In Stock |
|
| 1G | 88 | In Stock |
|
Biological Information
-
Product NameSalcaprozate sodium
-
NoteResearch use only, not for human use.
-
Brief DescriptionSalcaprozate sodium is an oral absorption promoter, and has the potential as a delivery agent for oral forms of heparin and insulin.
-
DescriptionSalcaprozate sodium is an oral absorption promoter, and has the potential as a delivery agent for oral forms of heparin and insulin.?It?could increase passive transcellular permeation across small intestinal epithelia based on increased lipophilicity arising from non-covalent macromolecule complexation.
-
In Vitro——
-
In VivoAnimal Model:Sprague-Dawley rats (6-7 weeks)Dosage:2000 mg/kg/d Administration:Oral gavage for 13 weeks Result:Induced 20% and 50% mortality in males and females at the dose of 2000 mg/kg/d.
-
SynonymsSNAC
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number203787-91-1
-
Formula Weight301.32
-
Molecular FormulaC15H20NNaO4
-
Purity>98% (HPLC)
-
SolubilityDMSO:100 mg/mL?(331.88 mM;?Need ultrasonic)
-
SMILESC1=CC=C(C(=C1)C(=O)NCCCCCCCC(=O)[O-])O.[Na+]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Li Y, et, al. Impact of Sodium N-[8-(2-Hydroxybenzoyl)amino]-caprylate on Intestinal Permeability for Notoginsenoside R1 and Salvianolic Acids in Caco-2 Cells Transport and Rat Pharmacokinetics. Molecules. 2018 Nov 16; 23(11):2990.
molnova catalog
related products
-
6-Bromovanillin
6-Bromovanillin is a biochemical reagent utilized in the synthesis of caridopa, an aromatic amino acid decarboxylase inhibitor.
-
CFI-402257
CFI-402257 is a orally active, and potent highly selective small-molecule inhibitor of Mps1 with Ki of 0.09 ± 0.02 nM.
-
Astin B
Astin B has antitumor activity.
